Cell-Based Assay for Protein Interaction Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing protein-protein and RNA-protein interactions in cellular contexts face challenges such as large surface areas of interaction, difficulty in drug development, and lack of reliable high-content screening approaches, leading to limited effective small molecule modulators reaching the market.
Innovation Solution
A method utilizing a polymerized-tubulin binding moiety fused to bait proteins or nucleic acids, allowing for the localization of candidate prey along microtubules, enabling single cell fluorescence microscopy for high-content screening to evaluate compound effects on interactions, thereby identifying potential medicament candidates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If HTRF method is used to monitor protein-protein interactions in cells, then sensitivity is improved, but device complexity and ease of operation worsen due to required protein labeling with antibodies or chemical linkage
Solution Approach 1:
The invention extracts the detection function from complex labeling procedures by using endogenous fluorescent proteins (GFP, RFP) that are already present in the cell, eliminating the need for antibody labeling or chemical linkage steps required by HTRF methods
Solution Approach 2:
The invention introduces an intermediary approach by using fluorescent proteins as natural markers that mediate detection without requiring external labeling reagents, thus simplifying the overall detection system while maintaining sensitivity
2Ease of operation
If FRET techniques are used to assess protein interactions in cells, then ease of operation is improved, but measurement precision worsens due to lack of sensitivity and low signal to noise ratio
Solution Approach 1:
The invention changes the detection parameters by using far-red fluorescent proteins (RFP, mCherry) with different excitation and emission wavelengths, which provide better signal separation and higher signal-to-noise ratio compared to traditional FRET wavelengths, while maintaining ease of operation in cellular environments
3Measurement precision
If NanoBRET assay is used to detect PPI, then measurement precision is improved, but device complexity increases due to requirement of stable cell lines expressing donor
Solution Approach 1:
The invention segments the detection system into separate transfection steps for bait and prey proteins, allowing flexible combination without requiring stable cell lines, thus reducing complexity while maintaining sensitivity through fluorescent protein-based detection
4Productivity
If in vitro methods are used to screen PPI inhibitors, then productivity is improved, but reliability worsens due to lack of information regarding compound efficiency in cellular environment
Solution Approach 1:
The invention creates a universal cell-based assay platform that can screen multiple compound libraries and target different protein interactions using the same fluorescent protein detection system, maintaining high productivity while ensuring reliability by conducting all screens in the same cellular environment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable and simple cell-based assay for screening small molecule modulators of protein-protein and RNA-protein interactions, improving the identification of effective compounds by integrating chemical, structural, and cellular data, and addressing the limitations of existing methods.
Implementation Method 1
said bait is bound to polymerized tubulin in the eukaryotic cell
Implementation Method 2
polymerized-tubulin binding moiety
Implementation Method 3
single cell fluorescence microscopy for high-content screening
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention covers an in vitro method for evaluating the ability of a compound to disrupt or stabilize an interaction between one or more bait and one or more candidate prey in a eukaryotic cell. In addition, the present invention covers compounds identified by the in vitro method according to any one of the preceding claims, for use as a medicament.